RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Antonio Baines to Antineoplastic Agents

This is a "connection" page, showing publications Antonio Baines has written about Antineoplastic Agents.
Connection Strength

0.547
  1. Baines AT, Xu D, Der CJ. Inhibition of Ras for cancer treatment: the search continues. Future Med Chem. 2011 Oct; 3(14):1787-808.
    View in: PubMed
    Score: 0.235
  2. Ingle K, LaComb JF, Graves LM, Baines AT, Bialkowska AB. AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor. PLoS One. 2023; 18(11):e0294065.
    View in: PubMed
    Score: 0.136
  3. Krulikas LJ, McDonald IM, Lee B, Okumu DO, East MP, Gilbert TSK, Herring LE, Golitz BT, Wells CI, Axtman AD, Zuercher WJ, Willson TM, Kireev D, Yeh JJ, Johnson GL, Baines AT, Graves LM. Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth. SLAS Discov. 2018 09; 23(8):850-861.
    View in: PubMed
    Score: 0.093
  4. Baines AT, Martin PM, Rorie CJ. Current and Emerging Targeting Strategies for Treatment of Pancreatic Cancer. Prog Mol Biol Transl Sci. 2016; 144:277-320.
    View in: PubMed
    Score: 0.083
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support